Preparation and Characterization of Pentoxyverine Citrate Micro-Nano Particle Aggregations


Article Preview

Micro-nano drug particle aggregations were prepared by shearing emulsification, high pressure homogenization and spray freeze drying, particle formational process and optimization of preparation conditions were analyzed, and micro-morphologies, particle size distributions, aerodynamic properties, release performances, inhalation and deposition properties were characterized. Results show that the optimum condition is drug supersaturation 2 and liquid feeding rate 800 mL/h. Micro morphologies of aggregations are porous spherical foamy structure formed by flaky micro-nano particles. The aggregations obtain both of the advantages of low density and large porous particles and micro-nano superficial particles. Tap density is only 0.062 g mL-1, mass median aerodynamic diameter is 0.93μm, aerosol availability is 59.8%, fine particle fraction is 15.80%, and more than 99% drugs dissolve within 5 min. All above properties are effective for drug delivery and release of DPI.



Edited by:

Prof. Dong Keon Kim




B. Chen et al., "Preparation and Characterization of Pentoxyverine Citrate Micro-Nano Particle Aggregations", Key Engineering Materials, Vol. 753, pp. 277-281, 2017

Online since:

August 2017




* - Corresponding Author

[1] S. A. Cryan. Carrier-based strategies for targeting protein and peptide drugs to the lungs, AAPS J. 7 (2005) 20-41.

[2] R. Vanbever, J. D. Mintzes, J. Wang, J. Nice, D. Chen, R. Langer, D. A. Edwards. Formulation and physical characterization of large porous particles for inhalation, Pharm. Res. 16 (1999) 1735-1742.

[3] C. Dunbar, G. K. Scheuch, M. Delong, A. Verma, R. Batycky. Invitro and invio dose delivery characteristics of large porous particles for inhalation, Int. J. Pharm. 245 (2002) 179-189.


[4] D. A. Edwards, C. Dunbar. Bioengineering of therapeutic aerosols, Annu. Rev. Biomed. Eng. 4 (2002) 93-107.

[5] M. T. Newhouse, P. H. Hirst, S. P. Duddu, Y. H. Walter, T. E. Tarara, A. R. Clark, J. G. Weers, Inhalation of a dry powder tobramycin pulmosphere formulation in healthy volunteers, Chest. 124 (2003) 360-366.


[6] C. M. Keck, R. H. Müller. Improved lung delivery from a passive dry powder inhaler using an engineered pulmosphere powder, Eur. J. Pharm. Biopharm. 62 (2006) 3-16.

[7] A Mihranyan, M. Stromme. Solubility of fractal nanoparticles, Surf. Sci. 601 (2007) 315-319.

[8] B. Chen, Y. P. Huang, H. Zhong, J. L. Jiao, C. P. Zou. Preparation of pentoxyverine citrate nano-particles by high pressure homogenization method, China Powd. Sci. Tech. 22 (2016) 18-21.